Author: admin

The Spanish society of Clinical Biochemistry and Molecular Pathology, committed to the ongoing training in the clinical laboratory.

the Spanish society of Clinical Biochemistry and Molecular Pathology, committed to the ongoing training in the laboratory clinical.

Each year, renewed up to 10 percent of knowledge in the area of the laboratory clinical

-scientific advances in analytical methodology and diagnostic procedures, in instrumental techniques, robotics or information systems lead to the clinical laboratory specialists should update its content constantly.

-distance training programme has registered 900, proof of the interest of professionals to the day.

-present courses of the SEQC gather more than 500 specialists in their activities.

-the virtual classroom is a step forward to provide updates to the specialist from their own workplace, saving time and energy to this supposed.

– society distance education programs are they are subjects as the ‘ validation of analytical reports ’, ‘ biochemical study of the perimenopause and menopause ’ or ‘ criteria for the realization of the Leukocyte formula manual ’.

-molecular biology and genetics, as well as new tumor markers or the development of information systems and telemedicine as a tool in the management information, are some of the key areas in the training of such specialists in the future.

Madrid, March 2010.- The evolution in the laboratory is the result of advances in research and in the Diagnostics industry. Thus, progress being made in speeding up reaction times to make the diagnosis of the patients as quickly as possible. Also, there is an evolution in the improvement of the technical precision of determinations and in increasing the reliability of the results of the laboratory. Other areas which perceives this remarkable progress are determinations at the bedside of the sick, in the use of ICT in the planning of the work and its communication with the medical analysis applicant.

For this reason, the Education Committee of the Spanish society of Clinical Biochemistry and Molecular Pathology (SEQC) continues with its commitment for the training in the area of clinical laboratory. Thus, it is currently carrying out its tenth third programme of distance training, which has registered 900.

The program consists of nine modules covering topics as the ‘ diagnosis of autosomal dominant hipercolesterolemias ’, ‘ HIV and laboratory ’ or ‘ pharmacological monitoring of immunosuppression ’. Other subjects covered include ‘ parathyroid hormone. Molecular forms and diagnostic utility ’, ‘ criteria for the implementation of the manual leukocyte formula ’ or ‘ C-reactive protein and cardiovascular disease ’.

Also, other subjects are taught as ‘ biochemical study of menopause and perimenopause the ’, ‘ diagnostic measurements fetal DNA in maternal blood: utility and clinical applications in developing ’ and ‘ validation of analytical reports ’.

This continuing distance education programs are accredited with 4.7 credits and have several advantages, such as self-assessment and the obtaining of a diploma at the end.

“ The SEQC has a long tradition of training since the beginning of its activity and currently devotes great effort to this ”, highlights the DRA. M. Carme Villá Blasco, President of the Education Committee of the society, who highlights the continuing distance in the clinical laboratory education program. “ It – explains – represents the practical application of scientific discoveries and is a very broad area, where specialization is increasingly ”.

The expert indicates that “ this profession requires a constant effort of training to maintain professional competence it is estimated that ten percent of knowledge are renewed, extend or technologically change every year ”. And is that scientific advances in methodology and diagnostic procedures, in instrumental techniques, robotics or information systems “ cause clinical laboratory practitioners must constantly update their content ”. Great participation in these programmes demonstrates the interest of professionals to the day.

As for the future, the expert maintains that the breadth of knowledge in the clinical laboratory requires professionals a dedication. For example, cited some issues that must be taken into account, such as “ molecular biology and genetics, not forgetting the new tumor markers or the development of information systems and telemedicine as tools in the management of the information ”.

In addition to this line to encourage the formation, the Spanish society of Clinical Biochemistry and Molecular Pathology has underway several courses of quality of the samples in the preanalítica phase, to be held in different Spanish cities. Also programmed a course on governance in the annual clinical laboratory and others on the management of waste, in an attempt to cover all areas of the analytic process: from the preparation of the patient and obtaining the sample until the final report of the results, as well as the correct management of waste. Face-to-face courses bring together more than 500 specialists in their activities.

Virtual

On the other hand, and of great interest are the seminars of the virtual classroom. Were made during 2009 attended half of 60 points of connection with an average of five participants point of connection.

For this year, next March 25 will start the new cycle of the virtual classroom with the theme of “ prevention of colon cancer and straight ”. Followed by this, on April 21 will take place which is entitled “ clinical value of determination of serum light chain ”. And on 26 the training seminar will be based in “ HE4 A new marker of interest in the diagnosis of ovarian cancer ”. To continue the training programme of this year will take place in the third quarter a meeting on “ assessment of the patient anemic. Current aspects of the study of erythropoiesis. All developed by specialists of the first order of our country

“ Finally, it should not be forgotten – highlights the head of the Education Committee of the SEQC – training is carried out through conferences and scientific meetings where they are exposed and discussed the scientific advances and where delves into the technical innovations ”.

The SEQC

The Spanish society of Clinical Biochemistry and pathology Molecular (SEQC) – founded in 1976, currently includes around 2,000 professionals and main aims to bring together all scientists interested in the clinical laboratory field, promote the dissemination of scientific and technical publicationsorganize meetings, courses and conferences on national and international levels and co-operate with other scientific societies. Also, the society wants to contribute to study and recommend standardised methods and to establish guidelines and recommendations for training in the field of Clinical Biochemistry and Molecular Pathology.

Read More

The relevance of the control of the cell death and the role of a gene in the battle against cancer.

the relevance of the control of the ‘ death ’ cell and the role of a gene in the battle against cancer.

It is published in the journal Clinical Cancer Research.

-The discovery represents a new breakthrough in knowledge of tumoral transformation and may have applications at the level of diagnosis and treatment.

Barcelona, July 2009.- The research group in pathological anatomy of the Institut de Recerca of l ’ Hospital Universitari Vall d ’ D’hebron of Barcelona has studied the role of the RSK4 as a possible tumor suppressor gene. The result of testing, in vitro, ratify the properties of the RSK4 gene to curb the growth of some types of cancer. Dr. Santiago Ramón y Cajal, responsible for this research, explains that the RSK4 get this surprising result “ inducing cells to limit their proliferation in renal tumors and colon ” details and findings of the research are published in the journal Clinical Cancer Research.

The cell as a suppressor of tumors mechanism senescence

Senescence is defined as the process by which a cell ceases to multiply and divide to move to a vegetative state or inactivity, which loses its proliferative ability. Therefore, the cells “ normal ” have a limited life and “ turn off ” when entering senescence. However, in the case of the tumor cells this process does not occur by what their proliferation does not cease. This “ immortality ” characterized the cancer cells are determined by an uncontrolled growth of tumors. Given that exceed the senescence is one of the basic initial requirements so that there is a malignant cell transformation, analyse the mechanisms which modulate the senescence can help develop more effective therapies against cancer.

RSK4 gen: an enemy of cancer

Previous studies on the cellular procedures involved in the early stages of the transformation of many solid tumors have identified several genes whose loss of functionality has been associated with cellular immortality or an induction delayed senescence. One of these genes is the RSK4 which, as noted above, is less active in a high percentage of renal tumors and colon. Researchers at the Institut de Recerca of l ’ Hospital Universitari Vall d ’ Hebron increased, through in-vitro tests, (activity) expression of RSK4 gene in colon carcinoma cell lines and noted that the presence of the RSK4 induced cellular senescence, thus slowing the growth of tumors. “ To the overexpress this gene test as very aggressive tumours stopped ”, assures us of the DRA. Gemma Armengol.

The next step

In the words of Dr. Santiago Ramón y Cajal, from the results obtained in the research, the aim is to “ study how it regulates the RSK4 and find a way of sobreactivarlo on tumor cells to induce them to senescence and stop proliferation ”. On the other hand, we need to get move in vitro results to real patients. With regard to possible applications of the discovery, Laura López, author of the doctoral thesis of which is a part of this study, explains that “ may be a marker forecast and serve at the level of diagnosis, to determine how to evolve a tumor ”.

Read More

Grünenthal Foundation and the extraordinary Chair of the pain of the University of Salamanca call Award for research in pain 2011

the extraordinary Chair of the pain of the University of Salamanca and la Fundación Grünenthal call Award for research in pain 2011

-The scientific work on pain resulting winner will get a prize of € 6,000

-applications may be submitted by the authors, both by people not associated with the work until 1 December

Madrid, July of 2011- the Foundation Grünenthal, in collaboration with the Chair special of the pain Foundation Grünenthal of the University of Salamanca, announces the award to the “ research in pain 2011 ”.

The best work on the pain will be rewarded with 6,000 euros. Seeks to thus recognize and promote scientific research related to the field of pain, both epidemiological and experimental, pharmacological or clinical.

All original and independent works that have been published in scientific journals from January 1 until December 1, 2011, may submit to this award. The work may be submitted by the authors themselves, as well as people who have not participated in the elaboration of the same.

Interested candidates must submit the work to the following address with the ID of the publication required:

Foundation Grünenthal
c / Dr. Zamenhof, no. 36
Madrid 28027,

or by e-mail to: fundacion.grunenthal@grunenthal.com.

The deadline for submission of these trials will be open until 1 December 2011.

The jury of the award to the “ research in pain 2011 ” will be formed by the rector of the University of Salamanca, the Chairman of the Board of Trustees of the Grünenthal Foundation, the director of the extraordinary Chair of pain “ Foundation Grünenthal ” of the University of Salamanca, as well as representatives of the Spanish society of pain (SED)the Spanish Rheumatology society (be) and the Sociedad Española de Oncología Médica.

The most innovative and interesting works can be collected and published by Grünenthal Foundation.

To check the basis or more information about this call, can be contacted at the following web pages:
www.fundaciongrunenthal.es www.catedradeldolor.com

on the Grünenthal Foundation

La Fundación Grünenthal is a private non-profit, with full capacity for work and own resources. With its motto “ live without pain, better ”, the Foundation defines his dedication to training, dissemination of scientific knowledge, collaboration with scientific societies and research support. These activities are carried out mainly in the fields of pain and palliative medicine and neurodegenerative diseases.

Read More

Air Liquide confirms its commitment to the safety of patients

Air Liquide confirms its commitment to the safety of patients

Air Liquide is one of the first industrial health which has signed the “Declaration of Helsinki to the safety of patients in anesthesia” during the 2011 Congress of the European society of Anaesthesiology in Amsterdam

Madrid, 2011-July this Declaration initiated by the European Board of Anesthesiology (EBA) and the society European de Anestesiología (ESA) has been adopted by the anestesia-reanimación European societies as a whole as well as by the World Health Organization.

Each year, about 230 million patients worldwide are anesthetized for operation of general surgery and a number of them develops secondary complications to the intervention itself.

The Helsinki Declaration is intended to reduce these complications Recalling the good clinical practice – particularly the respect for preoperative and surgical safety check-list – but also the key role of the anesthesiologist in the safety of the care and the importance of cooperation between manufacturers of health and the medical community.

Long suppliers of medicinal gases committed themselves to the safety of patients in the hospital using, for example, codes of colours and fittings differentiated depending on the type of gas bottles.

Air Liquide, the world leader of medicinal gases, used particularly in anestesia-reanimación, is a priority for the safety of patients and health professionals. The quality and safety of the gases and medical devices as well as associated services of the group – education of the health professionals in the use of medical gases, the traceability of products, warning system to ensure the continuity of the service, the management of the stock of bottles in hospitalillustrate the commitment of Air Liquide in the service of the safety of the patient.

For more information, see: Helsinki Declaration

Read More

That the pain is just a reminder, issue of art Grünenthal Prize II, dedicated to photography.

the pain is just a reminder, issue of the II prize of art Grünenthal, dedicated to photography.


-the first prize, worth 10,000 euros, will be released as c copy only.

the deadline for submission of entries is from August 20 to September 20, 2011.


Madrid, June of 2011- Grünenthal Pharma, pharmaceutical company regarding worldwide in the treatment of pain, launches its II art Prize dedicated to photography on the theme that the pain is only a memory. First prize is endowed with 10,000 euros and this second edition will present artists or groups of artists, Spanish or Portuguese, or of other nationality if they reside at Spain or Portugal.

a jury composed of prestigious personalities from the arts and medicine, will analyze the submitted works appreciating its artistic quality and its relevance to the theme of the contest. It is formed by D. Oscar Alonso Molina, art critic and independent curator, Dr. Manuel Alberto Camba, President of the Spanish society of pain, Dr. Duarte Correia, President of the Associaçao Portuguesa para o Estudo da Dor, D. Pierre Gonnord, photographer, Ms. Ivânia de Mendonça Gallo, Director of the fair of art contemporary art Lisbon, D. Alberto Schommer, photographer, D. Guillermo Solana, Chief Curator of the Thyssen-Bornemisza Museum and as the Secretariat of the same, Ms. Angelika Grundmann.


awards.

shall be granted a first prize endowed with 10,000 euros, which may not be divided, and three honorable mentions Honorable. photography awarded the first prize will be edited by its author as a single copy and will become part of the collection Grünenthal.

the participating artists must submit a single photographic work, consisting of one or several images, freely in the photographic technique used, under the overall theme of the pain relief and produced expressly for this call. Works that have been previously submitted in another contest will not be accepted. Also, participants must submit a test print of the work in the format deemed appropriate not exceeding the extent of A3, accompanied by a detailed description of the materials and dimensions which will present the work in case of being selected.

the proposals will be evaluated on dossier. Original works will not be accepted until the moment that are required by the Organization expressly. The work must be effectively produced and ready to display in the time of submitting the documentation.

the deadline for submission of dossiers is from August 20 to September 20, 2011.


about Grünenthal.

Grünenthal is a pharmaceutical company reference at global level in the treatment of pain for patients, doctors and health managers. Innovation is one of its fundamental principles and one of the keys to be leaders in the global market for moderate to severe pain. Grünenthal is an independent German company family-owned, with offices in 35 countries around the world. Founded in 1946, Grünenthal has 512 employees in the region of Iberia and approximately 4,900 at the global level. In 2009 the global sales figures reached the 881 million euros. Also, Grünenthal Pharma ranked 17 in the Group of companies of between 250 and 500 employees in the prestigious ranking ‘ Best WorkPlaces 2011 Spain ’, produced by Great Place to Work ®.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips